There is a suggestion that maintaining long-term TFR is not directly related to the total disposal of the gene transcript BCR::ABL1, but that it could possibly result from immune surveillance restoration in CML [6,7]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.